Testing HRS9531 for Type 2 Diabetes Blood Sugar Control
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–70 and diagnosed with type 2 diabetes for at least 6 months
- Blood sugar control level (HbA1c) between 7.5% and 10.5%
- Currently managing diabetes with lifestyle changes alone for 8+ weeks, or taking only metformin (stable dose) for 8+ weeks
- Fasting blood glucose not higher than 15 mmol/L and BMI between 20–40 kg/m²
- No recent severe low blood sugar episodes, heart attacks, strokes, or severe diabetes complications
- Willing to use contraception and not plan pregnancy for 2 months after the study ends
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This trial tests a new medicine, HS-20094, for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
Hear when a new T2DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.